Several of the LXRE genes predicted increased regression-free survival in breast cancer subjects (Table 2 and Fig 2B), among which Ptgs2, Mfge8, Anxa1, Spp1, S100a9 and Cd14 are biomarkers for MDSC and Treg cells (Table 3). This evidence concerns the gene CD14 and breast carcinoma.